Epigenomics offers IVD test development based on DNA methylation biomarkers. Epigenomics is establishing an IVD test platform for its own products by combining Epigenomics' proprietary DNA methylation technologies with pre-analytical solutions by Qiagen and the Affymetrix GCS3000Dx IVD platform.

DNA methylation IVD test development is also offered on other suitable platforms - e.g. using Epigenomics' proprietary real-time PCR based DNA methylation amplification technologies.

Development of a marketable IVD product will be conducted according to marketing requirements for an intended use established in cooperation with the partners.

Please contact us to discuss customized DNA methylation IVD test development partnerships.